# Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

> **NCT01463072** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **City of Hope Medical Center** · enrollment: 40 (actual)

## Conditions studied

- Locally Advanced Breast Carcinoma
- Metastatic Breast Carcinoma
- Recurrent Breast Carcinoma
- Stage III Breast Cancer AJCC v7
- Stage IIIA Breast Cancer AJCC v7
- Stage IIIB Breast Cancer AJCC v7
- Stage IIIC Breast Cancer AJCC v7
- Stage IV Breast Cancer AJCC v6 and v7

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Nab-paclitaxel
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT01463072
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2012-06-19
- **Primary completion:** 2017-05-17
- **Final completion:** 2026-05-18
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01463072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01463072, "Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01463072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*